Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

Illumina has a long history of driving advancements in genomics, providing the tools and technologies that have ...

In the rapidly evolving field of genomics, a new class of non-coding RNAs has captured the attention of researchers worldwide - circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs are ...

Refurbished DNA Sequencing platform Market. Refurbished DNA Sequencing Platform market – Comprehensive Study with focus on key drivers, trends, methodolo ...

The legal vindication arrives too late for Illumina, the U.S. gene-sequencing powerhouse, which spun off Grail as a stand-alone public company this summer to comply with government orders.

Illumina is improving human health by unlocking the power of the genome. Its focus on innovation has established it as the global leader in DNA sequencing and array-based technologies, serving ...

The DNA sequencing and array-based technologies provider noted that the court ruled that the European Commission did not have jurisdiction over Illumina's acquisition of GRAIL. According to the ...

Report on how AI is driving market transformation- The global bioinformatics market size is estimated to grow by USD ...